Terug
29
Dagbereik
€ 32,17
€ 33,36
52-Weeksbereik
€ 22,61
€ 50,71
Volume
945.398
50D / 200D Gem.
€ 37,13
/
€ 34,68
Vorige Slotkoers
€ 33,54
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 39,5 | 0,3 |
| P/B | 2,0 | 2,9 |
| ROE % | 5,3 | 3,7 |
| Net Margin % | 12,8 | 3,8 |
| Rev Growth 5Y % | 23,9 | 10,0 |
| D/E | 0,0 | 0,2 |
Koersdoel Analisten
Hold
€ 44,50
+35.1%
Low: € 37,00
High: € 50,00
Forward K/W
20,2
Forward WPA
€ 1,66
WPA Groei (sch.)
+0,0%
Omzet Sch.
580 M
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2030 |
€ 2,13
€ 2,09 – € 2,16
|
850 M | 1 |
| FY2029 |
€ 2,03
€ 1,99 – € 2,06
|
780 M | 1 |
| FY2028 |
€ 1,90
€ 1,58 – € 2,14
|
710 M | 3 |
Belangrijkste Punten
Revenue grew 23,89% annually over 5 years — strong growth
Earnings grew 174,89% over the past year
Debt/Equity of 0,03 — conservative balance sheet
Generating 126,63M in free cash flow
P/E of 39,45 — premium valuation
PEG of 0,31 suggests growth is underpriced
Groei
Revenue Growth (5Y)
23,89%
Revenue (1Y)16,01%
Earnings (1Y)174,89%
FCF Growth (3Y)92,25%
Kwaliteit
Return on Equity
5,34%
ROIC4,12%
Net Margin12,83%
Op. Margin14,34%
Veiligheid
Debt / Equity
0,03
Current Ratio8,15
Interest Coverage0,00
Waardering
P/E Ratio
39,45
P/B Ratio2,00
EV/EBITDA30,94
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16,01% | Revenue Growth (3Y) | 19,68% |
| Earnings Growth (1Y) | 174,89% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 23,89% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 517,15M | Net Income (TTM) | 66,35M |
| ROE | 5,34% | ROA | 4,72% |
| Gross Margin | 69,62% | Operating Margin | 14,34% |
| Net Margin | 12,83% | Free Cash Flow (TTM) | 126,63M |
| ROIC | 4,12% | FCF Growth (3Y) | 92,25% |
| Safety | |||
| Debt / Equity | 0,03 | Current Ratio | 8,15 |
| Interest Coverage | 0,00 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 39,45 | P/B Ratio | 2,00 |
| P/S Ratio | 5,06 | PEG Ratio | 0,31 |
| EV/EBITDA | 30,94 | Dividend Yield | 0,00% |
| Market Cap | 2,62B | Enterprise Value | 2,29B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 517,15M | 445,76M | 361,05M | 296,54M | 219,51M |
| Net Income | 66,35M | 24,14M | -74,40M | -36,56M | -75,56M |
| EPS (Diluted) | 0,82 | 0,31 | -1,02 | -0,51 | -1,11 |
| Gross Profit | 360,05M | 298,15M | 248,15M | 194,95M | 145,11M |
| Operating Income | 74,15M | 16,14M | -85,80M | -41,08M | -81,90M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,41B | 1,30B | 1,11B | 1,16B | 1,19B |
| Total Liabilities | 96,44M | 124,07M | 70,80M | 81,22M | 91,31M |
| Shareholders' Equity | 1,31B | 1,18B | 1,04B | 1,08B | 1,10B |
| Total Debt | 39,65M | 50,74M | 12,63M | 14,72M | 18,85M |
| Cash & Equivalents | 362,58M | 239,09M | 216,45M | 154,25M | 173,20M |
| Current Assets | 488,38M | 372,27M | 285,62M | 248,64M | 243,10M |
| Current Liabilities | 59,94M | 78,63M | 61,24M | 62,61M | 64,15M |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#846 of 1052
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026